$34.14
4.18% today
Nasdaq, Apr 04, 07:18 pm CET
ISIN
US49271V1008
Symbol
KDP
Industry

Keurig Dr Pepper Inc Target price 2025 - Analyst rating & recommendation

Keurig Dr Pepper Inc Classifications & Recommendation:

Buy
55%
Hold
45%

Keurig Dr Pepper Inc Price Target

Target Price $38.50
Price $35.63
Potential 8.06%
Number of Estimates 16
16 Analysts have issued a price target Keurig Dr Pepper Inc 2026 . The average Keurig Dr Pepper Inc target price is $38.50. This is 8.06% higher than the current stock price. The highest price target is $42.00 17.88% , the lowest is $34.00 4.57% .
A rating was issued by 20 analysts: 11 Analysts recommend Keurig Dr Pepper Inc to buy, 9 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Keurig Dr Pepper Inc stock has an average upside potential 2026 of 8.06% . Most analysts recommend the Keurig Dr Pepper Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028


Dec '24 2025
Estimates
Revenue Billion $ 15.35 16.12
3.62% 5.03%
EBITDA Margin 28.04% 30.20%
5.84% 7.69%
Net Margin 9.28% 16.53%
34.63% 78.13%

14 Analysts have issued a sales forecast Keurig Dr Pepper Inc 2025 . The average Keurig Dr Pepper Inc sales estimate is $16.1b . This is 5.03% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $16.4b 6.63% , the lowest is $15.8b 3.04% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $15.4b 3.62%
2025 $16.1b 5.03%
2026 $16.8b 3.99%
2027 $17.4b 3.89%
2028 $17.8b 2.06%

11 Analysts have issued an Keurig Dr Pepper Inc EBITDA forecast 2025. The average Keurig Dr Pepper Inc EBITDA estimate is $4.9b . This is 13.22% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.0b 16.61% , the lowest is $4.7b 9.30% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $4.3b 9.68%
2025 $4.9b 13.11%
2026 $5.1b 4.96%
2027 $5.4b 4.97%
2028 $5.3b 0.45%

EBITDA Margin

2024 28.04% 5.84%
2025 30.20% 7.69%
2026 30.48% 0.93%
2027 30.80% 1.05%
2028 30.04% 2.47%

6 Keurig Dr Pepper Inc Analysts have issued a net profit forecast 2025. The average Keurig Dr Pepper Inc net profit estimate is $2.7b . This is 87.06% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.8b 94.52% , the lowest is $2.5b 72.38% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $1.4b 32.26%
2025 $2.7b 87.06%
2026 $2.9b 8.65%
2027 $3.1b 6.62%
2028 $3.4b 9.51%

Net Margin

2024 9.28% 34.63%
2025 16.53% 78.13%
2026 17.27% 4.48%
2027 17.72% 2.61%
2028 19.01% 7.28%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028


Dec '24 2025
Estimates
Earnings Per Share $ 1.05 1.96
32.26% 86.67%
P/E 18.14
EV/Sales 4.04

6 Analysts have issued a Keurig Dr Pepper Inc forecast for earnings per share. The average Keurig Dr Pepper Inc EPS is $1.96 . This is 86.67% higher than earnings per share in the financial year 2024. The highest EPS forecast is $2.04 94.29% , the lowest is $1.81 72.38% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $1.05 32.26%
2025 $1.96 86.67%
2026 $2.13 8.67%
2027 $2.28 7.04%
2028 $2.49 9.21%

P/E ratio

Current 33.88 71.20%
2025 18.14 46.46%
2026 16.70 7.94%
2027 15.66 6.23%
2028 14.30 8.68%

Based on analysts' sales estimates for 2025, the Keurig Dr Pepper Inc stock is valued at an EV/Sales of 4.04 and an P/S ratio of 3.00 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.24 9.84%
2025 4.04 4.82%
2026 3.88 3.84%
2027 3.74 3.75%
2028 3.66 2.02%

P/S ratio

Current 3.15 9.61%
2025 3.00 4.78%
2026 2.88 3.84%
2027 2.78 3.75%
2028 2.72 2.02%

Current Keurig Dr Pepper Inc Upgrades & Downgrades

Analyst Rating Action Date
Morgan Stanley
Equal-Weight
Overweight
Upgrade Apr 01 2025
Barclays
Overweight
Overweight
Unchanged Feb 27 2025
JP Morgan
Overweight
Overweight
Unchanged Feb 26 2025
Morgan Stanley
Equal-Weight
Equal-Weight
Unchanged Feb 26 2025
Barclays
Overweight
Overweight
Unchanged Jan 17 2025
UBS
Buy
Buy
Unchanged Jan 16 2025
TD Cowen
Hold
Hold
Unchanged Jan 08 2025
Analyst Rating Date
Upgrade
Morgan Stanley:
Equal-Weight
Overweight
Apr 01 2025
Unchanged
Barclays:
Overweight
Overweight
Feb 27 2025
Unchanged
JP Morgan:
Overweight
Overweight
Feb 26 2025
Unchanged
Morgan Stanley:
Equal-Weight
Equal-Weight
Feb 26 2025
Unchanged
Barclays:
Overweight
Overweight
Jan 17 2025
Unchanged
UBS:
Buy
Buy
Jan 16 2025
Unchanged
TD Cowen:
Hold
Hold
Jan 08 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today